This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.70% per year. These returns cover a period from January 1, 1988 through April 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Top ETF of November & Its Best Stocks
by Sweta Killa
Amplify Seymour Cannabis ETF (CNBS) topped the list of the best-performing ETFs of November with impressive returns of more than 47%.
Small-Caps Beat Bigger Peers Last Week: 5 Top ETFs
by Sanghamitra Saha
The S&P 500, the Dow Jones, the Nasdaq Composite and the Russell 2000 put up a great show last week, with the Russell 2000 -- the small-cap index -- clocking the best performance.
5 Sector ETFs That Beat the Market in November
by Sweta Killa
We have highlighted a few ETFs that have outperformed the market in November and could be better plays if the trend prevails.
4 Top-Performing ETF Areas of Last Week
by Sanghamitra Saha
Last week was upbeat for Wall Street as vaccine hopes strengthened and consumers indulged in holiday shopping.
Should You Buy Cannabis Stocks & ETFs Now?
by Neena Mishra
CNBC's cannabis expert Tim Seymour discusses the recent developments in the space.
Can Small-Cap ETFs Keep Up the Winning Trend in November?
by Sanghamitra Saha
The month of October was downbeat for Wall Street due to election uncertainty, failed stimulus talks, subdued tech earnings and rising coronavirus cases on the global front.
Why Cannabis Stocks & ETFs Are Soaring
by Neena Mishra
Marijuana stocks are rising on hopes of favorable regulatory environment
Cannabis ETFs Hot Ahead of Elections: Here's Why?
by Sweta Killa
With the election just a day away, five states are seeking to legalize marijuana through ballot measures.
Healthcare ETFs: Winners & Losers in the Light of U.S. Election
by Sanghamitra Saha
The coronavirus vaccine development effort has put the spotlight on the U.S. healthcare sector in recent months.
Is it Time to Buy Cannabis Stocks & ETFs?
by Neena Mishra
CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.